Navya Network, Inc. was founded in 2010 in Cambridge, MA, USA. The company began its mission in cancer informatics by partnering with leading cancer centers to enable rapid, online, multi-disciplinary expert reviews and 2nd opinion services. Operating in Bangalore, India as "Navya Care" since 2012, the company offers cancer patients affordable personalized cancer treatment plans from expert oncologists in India and the U.S. The company's B2C model has been used to help more than 80,000 cancer patients from across India and surrounding countries.

The Navya team expanded its portfolio by developing and delivering the Navya Cancer Data Model for the U.S., U.K., and EU markets in 2020. The Navya Cancer Data Model is a cancer-specific ontology derived from published medical evidence, clinical trial data, patient information (treatment history, medical records, and treatment preferences), and structured treatment options from leading cancer experts. The result is a compact representation of clinically necessary and sufficient terms required by an oncologist at the time of treatment selection.

The Navya Cancer Data Model was designed to answer the critical questions that patients and doctors face at the moment of treatment selection. This is by far the most demanding scenario in a clinical data model.

The Navya Cancer Data Model is designed as a search application to output clinically meaningful results on the adequacy of data to make decisions on treatment selection and clinical trial eligibility.

The Navya Cancer Data Model provides a rich representation of the universe of clinical data elements necessary to make a clinical decision for an individual patient. Contact us for a detailed workflow map.

In IRB-approved clinical validation trials conducted between 2013 and 2017, Tata Memorial Hospital and Olive View-UCLA Medical Center demonstrated concordance of the Navya Cancer Data Model matched evidence-based treatment options with multidisciplinary tumor board decisions and NCCN Guidelines. (SABCS 2014, ASCO 2016, SABCS 2017).

In a recent study co-authored by faculty at Memorial Sloan-Kettering Cancer Center and presented at ASCO 2021, the Navya Cancer Data Model enabled cancer experts to review clinical record summaries in an average time of <4 minutes and make a treatment decision with ease in 95.7% of cases. Other clinical validations and patient impact studies are available on our Scientific Conferences page.

In a separate study co-authored by two leading cancer providers in India (Tata Memorial Hospital and The National Cancer Grid) and presented at ASCO 2017, 73% of patients shared the Navya "Structured Treatment Options" with their treating oncologists, and 78% received the recommended treatments.

In a study co-authored by the same two groups and presented at ASCO 2020, the online services provided by Navya resulted in 50% of patients changing their treatment decision from non-guidelines compliant to guidelines compliant care.

Yes. When oncologists or care team members are tasked with structuring complex patient records comprising hundreds of pages of reports i.e. clinical history, diagnosis, and treatments, a significant amount of high-value time is spent on record summarization instead of care delivery. This approach cannot scale to tens of thousands of patients. Moreover, using nursing or clinician time to review unstructured reports (vs. offering structured storytelling) is an extremely inefficient use of scarce resources.

Furthermore, structured case summaries can be searched for insights at a granular level of individual patient data, such as details within treatment histories, toxicities, and treatment responses. These may be utilized to find patients that match specific eligibility criteria for clinical trials or to explore possibilities with real-world evidence. This outcome is not possible without structuring based on technology and a data model.

A retrospective trial of Navya’s Evidence Engine revealed that our structured treatment recommendations are 98.6% concordant with the decisions of tumor boards and expert oncologists at The UCLA Olive View Medical Center and Tata Memorial Centre.

In a study presented at SABCS 2017 and NCCN 2018, patients experienced a 97% reduction in anxiety by receiving Navya's "Structured Treatment Options" within 24 hours. In another study presented at ESMO 2019, patients saved 3-5 days and over $1,800 out-of-pocket expenses by leveraging online expert reviews vs. waiting for in-person consultations. The Navya solution is conducive to delivering a high-quality experience to patients, experts, and hospitals, and saves time and cost by leveraging a semi-automated clinical record summarization and patient report generation technology driven by NCDM.